论文信息 - PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial - 字舞流文

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial

Sung-Bae Kim | M. Buyse | N. Robert | M. Gnant | H. Iwata | C. Barrios | G. von Minckwitz | S. Chia | F. Holmes | B. Moy | V. Harvey | S. Delaloge | J. Mansi | Miguel Martín | B. Ejlertsen | L. Eli | A. Lalani | E. Jakobsen | Y. Ye | Z. Tomašević | R. Šeparović | N. Denduluri | G. Harker | Bo Zhang | John A. Smith | A. Chan